These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 7961028

  • 21. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme.
    Levin VA, Maor MH, Thall PF, Yung WK, Bruner J, Sawaya R, Kyritsis AP, Leeds N, Woo S, Rodriguez L.
    Int J Radiat Oncol Biol Phys; 1995 Sep 30; 33(2):357-64. PubMed ID: 7673023
    [Abstract] [Full Text] [Related]

  • 22. Combination chemotherapy with carmustine and cisplatin before, during, and after radiotherapy for adult malignant gliomas.
    Kiu MC, Chang CN, Cheng WC, Lin TK, Wong CW, Tang SG, Leung WM, Chen LH, Ho YS, Ng KT.
    J Neurooncol; 1995 Sep 30; 25(3):215-20. PubMed ID: 8592171
    [Abstract] [Full Text] [Related]

  • 23. Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas.
    Jeremic B, Jovanovic D, Djuric LJ, Jevremovic S, Mijatovic LJ.
    J Chemother; 1992 Apr 30; 4(2):123-6. PubMed ID: 1321239
    [Abstract] [Full Text] [Related]

  • 24. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
    Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y.
    Cancer; 1983 Sep 15; 52(6):997-1007. PubMed ID: 6349785
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
    Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB.
    Int J Radiat Oncol Biol Phys; 1990 Feb 15; 18(2):321-4. PubMed ID: 2154418
    [Abstract] [Full Text] [Related]

  • 27. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
    Liau CT, Wei KC, Tseng CK, Jung SM.
    Chang Gung Med J; 2005 Jan 15; 28(1):16-23. PubMed ID: 15804144
    [Abstract] [Full Text] [Related]

  • 28. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
    Levin VA, Wara WM, Davis RL, Vestnys P, Resser KJ, Yatsko K, Nutik S, Gutin PH, Wilson CB.
    J Neurosurg; 1985 Aug 15; 63(2):218-23. PubMed ID: 2991486
    [Abstract] [Full Text] [Related]

  • 29. Hyperfractionated radiotherapy and multi-agent chemotherapy (procarbazine, ACNU and vincristine) for high-grade gliomas: a prospective study.
    Ogawa K, Yoshii Y, Toita T, Saito A, Kakinohana Y, Iraha S, Sugimoto K, Tsuchida Y, Tamaki W, Adachi G, Hyodo A, Murayama S.
    Anticancer Res; 2006 Aug 15; 26(3B):2457-62. PubMed ID: 16821632
    [Abstract] [Full Text] [Related]

  • 30. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
    Sullivan FJ, Herscher LL, Cook JA, Smith J, Steinberg SM, Epstein AH, Oldfield EH, Goffman TE, Kinsella TJ, Mitchell JB.
    Int J Radiat Oncol Biol Phys; 1994 Oct 15; 30(3):583-90. PubMed ID: 7928489
    [Abstract] [Full Text] [Related]

  • 31. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
    Halperin EC, Gaspar L, Imperato J, Salter M, Herndon J, Dowling S.
    Am J Clin Oncol; 1993 Aug 15; 16(4):277-83. PubMed ID: 8392285
    [Abstract] [Full Text] [Related]

  • 32. Early chemotherapy and concurrent radio-chemotherapy in high grade glioma.
    Brandes AA, Rigon A, Zampieri P, Scelzi E, Amistà P, Berti F, Rotilio A, Gardiman M, Fiorentino MV.
    J Neurooncol; 1996 Dec 15; 30(3):247-55. PubMed ID: 8943100
    [Abstract] [Full Text] [Related]

  • 33. A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02.
    Curran WJ, Scott CB, Nelson JS, Weinstein AS, Phillips TL, Murray K, Fischbach AJ, Yakar D, Schwade JG, Powlis WD.
    Cancer; 1992 Dec 15; 70(12):2909-17. PubMed ID: 1451073
    [Abstract] [Full Text] [Related]

  • 34. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
    Fernández-Hidalgo OA, Vanaclocha V, Vieitez JM, Aristu JJ, Rebollo J, Gúrpide A, Aramendía JM, Moreno-Palanques R, Martín-Algarra S, Subirá ML, Brugarolas A.
    Bone Marrow Transplant; 1996 Jul 15; 18(1):143-9. PubMed ID: 8832007
    [Abstract] [Full Text] [Related]

  • 35. The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma.
    Kleinberg L, Grossman SA, Piantadosi S, Zeltzman M, Wharam M.
    Int J Radiat Oncol Biol Phys; 1999 Jun 01; 44(3):535-43. PubMed ID: 10348282
    [Abstract] [Full Text] [Related]

  • 36. A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.
    Groves MD, Maor MH, Meyers C, Kyritsis AP, Jaeckle KA, Yung WK, Sawaya RE, Hess K, Bruner JM, Peterson P, Levin VA.
    Int J Radiat Oncol Biol Phys; 1999 Aug 01; 45(1):127-35. PubMed ID: 10477016
    [Abstract] [Full Text] [Related]

  • 37. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
    Levin VA, Yung WK, Bruner J, Kyritsis A, Leeds N, Gleason MJ, Hess KR, Meyers CA, Ictech SA, Chang E, Maor MH.
    Int J Radiat Oncol Biol Phys; 2002 May 01; 53(1):58-66. PubMed ID: 12007942
    [Abstract] [Full Text] [Related]

  • 38. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD, Scott CB, Rotman M, Rubin P, Murray K, Sause W, Asbell S, Comis R, Curran W, Nelson J, Davis RL, Levin VA, Lamborn K, Phillips TL.
    Int J Radiat Oncol Biol Phys; 1998 Feb 01; 40(3):653-9. PubMed ID: 9486616
    [Abstract] [Full Text] [Related]

  • 39. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery.
    Rostomily RC, Spence AM, Duong D, McCormick K, Bland M, Berger MS.
    Neurosurgery; 1994 Sep 01; 35(3):378-88; discussion 388. PubMed ID: 7800129
    [Abstract] [Full Text] [Related]

  • 40. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.
    Dinapoli RP, Brown LD, Arusell RM, Earle JD, O'Fallon JR, Buckner JC, Scheithauer BW, Krook JE, Tschetter LK, Maier JA.
    J Clin Oncol; 1993 Jul 01; 11(7):1316-21. PubMed ID: 8315428
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.